217 related articles for article (PubMed ID: 23871820)
1. Similarity-based virtual screening for microtubule stabilizers reveals novel antimitotic scaffold.
Ayoub AT; Klobukowski M; Tuszynski J
J Mol Graph Model; 2013 Jul; 44():188-96. PubMed ID: 23871820
[TBL] [Abstract][Full Text] [Related]
2. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
[TBL] [Abstract][Full Text] [Related]
3. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel microtubule stabilizers targeting taxane binding site by applying molecular docking, molecular dynamics simulation, and anticancer activity testing.
Zhang H; Qi HZ; Mao J; Zhang HR; Luo QQ; Hu ML; Shen C; Ding L
Bioorg Chem; 2022 May; 122():105722. PubMed ID: 35303622
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent microtubule-destabilizing agents targeting for colchicine site by virtual screening, biological evaluation, and molecular dynamics simulation.
Zhang H; Luo QQ; Hu ML; Wang N; Qi HZ; Zhang HR; Ding L
Eur J Pharm Sci; 2023 Jan; 180():106340. PubMed ID: 36435355
[TBL] [Abstract][Full Text] [Related]
6. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
[TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
8. Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers by in silico molecular docking, molecular dynamics, and binding free energy calculations.
Tripathi S; Kumar A; Kumar BS; Negi AS; Sharma A
J Biomol Struct Dyn; 2016 Jun; 34(6):1232-40. PubMed ID: 26212016
[TBL] [Abstract][Full Text] [Related]
9. The Unique Binding Mode of Laulimalide to Two Tubulin Protofilaments.
Churchill CD; Klobukowski M; Tuszynski JA
Chem Biol Drug Des; 2015 Aug; 86(2):190-9. PubMed ID: 25376845
[TBL] [Abstract][Full Text] [Related]
10. High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.
Xiao Q; Xue T; Shuai W; Wu C; Zhang Z; Zhang T; Zeng S; Sun B; Wang Y
Biochem Biophys Res Commun; 2021 Jan; 534():330-336. PubMed ID: 33272565
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
Tripathi S; Srivastava G; Sharma A
Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
[TBL] [Abstract][Full Text] [Related]
14. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel class of tubulin inhibitors with promising anticancer activities.
Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
[TBL] [Abstract][Full Text] [Related]
16. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
17. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
[TBL] [Abstract][Full Text] [Related]
18. The microtubule-pore gatekeeper.
Snyder JP
Nat Chem Biol; 2007 Feb; 3(2):81-2. PubMed ID: 17235340
[No Abstract] [Full Text] [Related]
19. Elucidating the mechanism of action of the clinically approved taxanes: a comprehensive comparison of local and allosteric effects.
Churchill CD; Klobukowski M; Tuszynski JA
Chem Biol Drug Des; 2015 Nov; 86(5):1253-66. PubMed ID: 26032329
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel tubulin inhibitors targeting taxanes site by virtual screening, molecular dynamic simulation, and biological evaluation.
Zhang H; Mao J; Yang YL; Liu CT; Shen C; Zhang HR; Xie HZ; Ding L
J Cell Biochem; 2021 Nov; 122(11):1609-1624. PubMed ID: 34237164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
